A Randomized Controlled Trial of ACT-P Versus T4C for Community Reentry
Launched by IOWA STATE UNIVERSITY · Oct 27, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The proposed study will focus on medium to high risk adult males, currently institutionalized and approaching release, who will be randomized to Acceptance and Commitment Therapy for prisons (ACT-P) or the Thinking for a Change (T4C) program. ACT-P is a cognitive behavioral treatment that targets acceptance and mindfulness processes to reduce criminal behavior, and has been adapted for the prison setting. T4C is a widely used and well-established traditional cognitive behavioral program that targets changing criminal thinking.
The first aim of the study is to test the relative efficacy of ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • deemed medium or high risk according to the Iowa Risk Revised
- • eligible and appropriate for cognitive programming as determined by normal operating procedures
- Exclusion Criteria:
- • court-mandated to either program
About Iowa State University
Iowa State University (ISU) is a renowned research institution committed to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, ISU leverages its expertise in agriculture, engineering, and health sciences to conduct cutting-edge research that addresses pressing health challenges. The university's clinical trial programs are designed to uphold the highest ethical standards and regulatory compliance, fostering a safe environment for participants while contributing valuable insights to the medical community. ISU's dedication to education, research excellence, and community engagement positions it as a leader in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort Dodge, Iowa, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials